(PRESS RELEASE) As part of its ongoing commitment to advancing myopia management, CooperVision convened leading U.S. and Canadian eye care professionals (ECPs) at its annual Myopia Luminaries event in Las Vegas on January 7. Held ahead of the Global Specialty Lens Symposium (GSLS 2026), the event spotlighted the central role of ECPs in shaping the future of myopia care, bringing together clinical evidence, real-world outcomes, and emerging best practices.
Presentations and discussions featured insights from Dr. Mark Bullimore, who emphasized the importance of clearly defining treatment efficacy in myopia management. Additional sessions explored how evidence-based, FDA-approved therapies can bring greater consistency and confidence to clinical decision making. The program also addressed the human side of myopia management, with Dr. Shimi Kang highlighting communication strategies that build trust, counter misinformation, and support families through empathy and collaboration.
Dr. Kylvin Ho shares 24-month real-world patient outcomes using MiSight Spectacle Lenses with Diffusion Optics Technology in Canada.
Canadian clinicians contributed real-world perspectives on accessible, patient-centered care. Dr. Shalu Pal, Dr. Vishakha Thakrar, and Dr. Kylvin Ho shared clinical outcomes and emphasized the importance of practice leadership and a comprehensive myopia management portfolio during a panel moderated by Dr. Nathalie Trottier, Senior Manager Professional and Academic Affairs Canada.
The event reaffirmed the essential role of ECPs in guiding families, personalizing treatment decisions, and delivering meaningful long-term outcomes for children with myopia.
For more information, visit MiSight.com.
Advertisement
Vision Source ECPs at the Myopia Luminaries Forum.
